Keywords: kinase inhibitors/minicolumns/traumatic brain injury/fragile X syndrome/interneurons/Angelman syndrome/drug resistance

Representative Publications

Nobiletin in Cancer Therapy; Mechanisms and Therapy Perspectives

Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths

Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)